Global Women Reproductive Health Market : Analysis By Treatment Type, By Route of Administration, By End User, By Region: Market Insights and Forecast

Azoth Analytics has released a research report titled "Global Women Reproductive Health Market (2024 Edition)" which provides a complete analysis of the Global Women Reproductive Health industry in terms of market segmentation by Treatment Type (Menstrual Disorder, Uterine Fibroids/ Endometriosis, Infertility, Menopausal Disorder), by Route of Administration (Oral, Parenteral), by End User (Hospitals, Specialty Centers, At-Home) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.

The report analyses the Women Reproductive Health Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, United Kingdom, Germany, France, Italy, Spain, China, India, Japan). The Global Women Reproductive Health market showcased growth at a CAGR of 3.50% during 2020-2023. The market was valued at USD 6.39 Billion in 2023 which is expected to reach USD 8.42 Billion in 2030. The market for Women Reproductive Health has seen significant growth due to advancements in medical research, demographic trends influencing healthcare needs, regulatory landscapes, and the growing demand for effective treatments that enhance reproductive health and well-being across different stages of women's lives. Pharmaceutical companies innovate to develop new therapies, improve existing treatments, and meet the evolving healthcare needs of women globally, contributing significantly to healthcare advancements in this specialized field.

Several key drivers influence the growth of the global women's health market. Increasing awareness and education about women's health issues are fundamental drivers. As knowledge about the importance of reproductive health, early detection of gynecological conditions, and the benefits of family planning spreads, demand for related pharmaceutical products increases. Also, the rise in female workforce participation also plays a crucial role. With more women prioritizing their careers and delaying childbearing, there is a higher need for effective contraception and fertility treatments. This trend is particularly noticeable in urban areas of both developed and developing countries.

Technological advancements are at the heart of the evolution of the women's health drug market. In the field of contraception, innovations like long-acting reversible contraceptives (LARCs) have transformed family planning options. LARCs, which include IUDs and hormonal implants, offer effective, long-term contraception with minimal user intervention, appealing to a wide demographic. In fertility treatments, advancements in ART, particularly IVF, have revolutionized the approach to infertility. The development of sophisticated hormonal therapies that enhance ovulation and support early pregnancy stages has significantly improved the success rates of ART procedures. Additionally, the advent of genetic screening technologies allows for better selection of viable embryos, further increasing the chances of successful pregnancies.

Hormone replacement therapy (HRT) has also seen significant technological advancements. New formulations and delivery systems have been developed to enhance the safety and efficacy of HRT. Transdermal patches, gels, and sprays provide alternative delivery methods to oral HRT, offering more consistent hormone levels and reducing the risk of side effects associated with oral administration. Bioidentical hormone therapies, which use hormones that are chemically identical to those produced by the human body, are gaining popularity for their perceived safety and efficacy. Advances in compounding techniques allow for personalized HRT formulations tailored to individual needs, further improving patient outcomes.

Oral administration remains one of the most common routes for women's health drugs, particularly contraceptives and HRT. However, advancements in formulation technology have led to the development of extended-release tablets and capsules, which provide more consistent drug levels and reduce the frequency of dosing. This is particularly beneficial for oral contraceptives, where missed doses can significantly reduce effectiveness. Extended-release formulations help to improve adherence and maintain therapeutic efficacy.

Hospitals and clinics are primary end users of women's health drugs, particularly for fertility treatments and complex gynecological conditions. Technological advancements in diagnostic tools and treatment protocols have enhanced the ability of healthcare providers to diagnose and manage reproductive health issues. Advanced imaging technologies, such as transvaginal ultrasound and magnetic resonance imaging (MRI), provide detailed visualization of reproductive organs, aiding in the diagnosis of conditions like endometriosis and fibroids. In fertility clinics, the use of advanced laboratory technologies, such as time-lapse imaging and genetic screening, has improved IVF success rates and patient outcomes.

Scope of the Report:

The report analyses the Women Reproductive Health Market by Value (USD Million).
The report analyses the Women Reproductive Health Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, United Kingdom, Germany, France, Italy, Spain, China, India, Japan).
The report analyses the Women Reproductive Health Market by Epidemiology.
The report analyses the Women Reproductive Health Market by Pipeline Scenario.
The report presents the analysis of Women Reproductive Health Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
The report analyses the Women Reproductive Health Market by Treatment Type (Menstrual Disorder, Uterine Fibroids/ Endometriosis, Infertility, Menopausal Disorder).
The report analyses the Women Reproductive Health Market by Route of Administration (Oral, Parenteral).
The report analyses the Women Reproductive Health Market by End User (Hospitals, Specialty Centers, At-Home).
The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by treatment type, by route of administration, & by end user.
Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Amgen, Inc., Teva Pharmaceutical, Merck & Co., Inc., Bayer AG, AbbVie Inc., Agile Therapeutics Inc., Pfizer Inc., Glenmark Pharmaceuticals Ltd., AstraZeneca PLC., Ferring Pharmaceuticals.

1. Market Background

1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology

2. Strategic Recommendations

2.1 Focus on educational market campaign
2.2 Amplify prevalence across remote areas of developing countries

3. Global Women Reproductive Health Market: Historic and Forecast

3.1 Impact Analysis of Macro Economic Factors on Global Women Reproductive Health Market
3.2 Epidemiology: Global Gynecological Disease Prevalence
3.3 Epidemiology: Global Gynecological Disease Incidence
3.4 Pipeline Scenario
3.5 Global Women Reproductive Health Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
3.6 Global Women Reproductive Health Market Segmentation: By Treatment Type
- 3.6.1 Global Women Reproductive Health Market, By Treatment Type Overview
- 3.6.2 Global Women Reproductive Health Market Attractiveness Index, By Treatment Type Overview
- 3.6.3 Global Women Reproductive Health Market Size, By Menstrual Disorder, By Value, 2020H-2030F (USD Million & CAGR)
- 3.6.4 Global Women Reproductive Health Market Size, By Uterine Fibroids/ Endometriosis, By Value, 2020H-2030F (USD Million & CAGR)
- 3.6.5 Global Women Reproductive Health Market Size, By Infertility, By Value, 2020H-2030F (USD Million & CAGR)
- 3.6.6 Global Women Reproductive Health Market Size, By Menopausal Disorder, By Value, 2020H-2030F (USD Million & CAGR)
3.7 Global Women Reproductive Health Market Segmentation: By Route of Administration
- 3.7.1 Global Women Reproductive Health Market, By Route of Administration Overview
- 3.7.2 Global Women Reproductive Health Market Attractiveness Index, By Route of Administration Overview
- 3.7.3 Global Women Reproductive Health Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR)
- 3.7.4 Global Women Reproductive Health Market Size, By Parenteral, By Value, 2020H-2030F (USD Million & CAGR)
3.8 Global Women Reproductive Health Market Segmentation: By End User
- 3.8.1 Global Women Reproductive Health Market, By End User Overview
- 3.8.2 Global Women Reproductive Health Market Attractiveness Index, By End User Overview
- 3.8.3 Global Women Reproductive Health Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
- 3.8.4 Global Women Reproductive Health Market Size, By Specialty Centers, By Value, 2020H-2030F (USD Million & CAGR)
- 3.8.5 Global Women Reproductive Health Market Size, By At-Home, By Value, 2020H-2030F (USD Million & CAGR)

4. Global Women Reproductive Health Market, Region Analysis

4.1 Regional Coverage of the Study
4.2 Regional Snapshot

5. Americas Women Reproductive Health Market: Historic and Forecast

5.1 Americas Women Reproductive Health Market: Snapshot
5.2 Americas Women Reproductive Health Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.3 Americas Women Reproductive Health Market: Key Factors
5.4 Americas Women Reproductive Health Market: Segment Analysis
5.5 Americas Women Reproductive Health Market Segmentation: By Treatment Type
- 5.5.1 Americas Women Reproductive Health Market, By Treatment Type Overview
- 5.5.2 Americas Women Reproductive Health Market Size, By Menstrual Disorder, By Value, 2020H-2030F (USD Million & CAGR)
- 5.5.3 Americas Women Reproductive Health Market Size, By Uterine Fibroids/ Endometriosis, By Value, 2020H-2030F (USD Million & CAGR)
- 5.5.4 Americas Women Reproductive Health Market Size, By Infertility, By Value, 2020H-2030F (USD Million & CAGR)
- 5.5.5 Americas Women Reproductive Health Market Size, By Menopausal Disorder, By Value, 2020H-2030F (USD Million & CAGR)
5.6 Americas Women Reproductive Health Market Segmentation: By Route of Administration
- 5.6.1 Americas Women Reproductive Health Market, By Route of Administration Overview
- 5.6.2 Americas Women Reproductive Health Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR)
- 5.6.3 Americas Women Reproductive Health Market Size, By Parenteral, By Value, 2020H-2030F (USD Million & CAGR)
5.7 Americas Women Reproductive Health Market Segmentation: By End User
- 5.7.1 Americas Women Reproductive Health Market, By End User Overview
- 5.7.2 Americas Women Reproductive Health Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
- 5.7.3 Americas Women Reproductive Health Market Size, By Specialty Centers, By Value, 2020H-2030F (USD Million & CAGR)
- 5.7.4 Americas Women Reproductive Health Market Size, By At-Home, By Value, 2020H-2030F (USD Million & CAGR)
5.8 Americas Women Reproductive Health Market Segmentation: By Country
- 5.8.1 Europe Women Reproductive Health Market, By Country Overview
- 5.8.2 United States Women Reproductive Health Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
  - 5.8.2.1 United States Women Reproductive Health Market, By Treatment Type
  - 5.8.2.2 United States Women Reproductive Health Market, By Route of Administration
  - 5.8.2.3 United States Women Reproductive Health Market, By End User
- 5.8.3 Canada Women Reproductive Health Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
  - 5.8.3.1 Canada Women Reproductive Health Market, By Treatment Type
  - 5.8.3.2 Canada Women Reproductive Health Market, By Route of Administration
  - 5.8.3.3 Canada Women Reproductive Health Market, By End User
- 5.8.4 Rest of Americas Women Reproductive Health Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
  - 5.8.4.1 Rest of Americas Women Reproductive Health Market, By Treatment Type
  - 5.8.4.2 Rest of Americas Women Reproductive Health Market, By Route of Administration
  - 5.8.4.3 Rest of Americas Women Reproductive Health Market, By End User

6. Europe Women Reproductive Health Market: Historic and Forecast

6.1 Europe Women Reproductive Health Market: Snapshot
6.2 Europe Women Reproductive Health Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.3 Europe Women Reproductive Health Market: Key Factors
6.4 Europe Women Reproductive Health Market: Segment Analysis
6.5 Europe Women Reproductive Health Market Segmentation: By Treatment Type
- 6.5.1 Europe Women Reproductive Health Market, By Treatment Type Overview
- 6.5.2 Europe Women Reproductive Health Market Size, By Menstrual Disorder, By Value, 2020H-2030F (USD Million & CAGR)
- 6.5.3 Europe Women Reproductive Health Market Size, By Uterine Fibroids/ Endometriosis, By Value, 2020H-2030F (USD Million & CAGR)
- 6.5.4 Europe Women Reproductive Health Market Size, By Infertility, By Value, 2020H-2030F (USD Million & CAGR)
- 6.5.5 Europe Women Reproductive Health Market Size, By Menopausal Disorder, By Value, 2020H-2030F (USD Million & CAGR)
6.6 Europe Women Reproductive Health Market Segmentation: By Route of Administration
- 6.6.1 Europe Women Reproductive Health Market, By Route of Administration Overview
- 6.6.2 Europe Women Reproductive Health Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR)
- 6.6.3 Europe Women Reproductive Health Market Size, By Parenteral, By Value, 2020H-2030F (USD Million & CAGR)
6.7 Europe Women Reproductive Health Market Segmentation: By End User
- 6.7.1 Europe Women Reproductive Health Market, By End User Overview
- 6.7.2 Europe Women Reproductive Health Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
- 6.7.3 Europe Women Reproductive Health Market Size, By Specialty Centers, By Value, 2020H-2030F (USD Million & CAGR)
- 6.7.4 Europe Women Reproductive Health Market Size, By At-Home, By Value, 2020H-2030F (USD Million & CAGR)
6.8 Europe Women Reproductive Health Market Segmentation: By Country
- 6.8.1 Europe Women Reproductive Health Market, By Country Overview
- 6.8.2 United Kingdom Women Reproductive Health Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
  - 6.8.2.1 United Kingdom Women Reproductive Health Market, By Treatment Type
  - 6.8.2.2 United Kingdom Women Reproductive Health Market, By Route of Administration
  - 6.8.2.3 United Kingdom Women Reproductive Health Market, By End User
- 6.8.3 Germany Women Reproductive Health Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
  - 6.8.3.1 Germany Women Reproductive Health Market, By Treatment Type
  - 6.8.3.2 Germany Women Reproductive Health Market, By Route of Administration
  - 6.8.3.3 Germany Women Reproductive Health Market, By End User
- 6.8.4 France Women Reproductive Health Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
  - 6.8.4.1 France Women Reproductive Health Market, By Treatment Type
  - 6.8.4.2 France Women Reproductive Health Market, By Route of Administration
  - 6.8.4.3 France Women Reproductive Health Market, By End User
- 6.8.5 Italy Women Reproductive Health Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
  - 6.8.5.1 Italy Women Reproductive Health Market, By Treatment Type
  - 6.8.5.2 Italy Women Reproductive Health Market, By Route of Administration
  - 6.8.5.3 Italy Women Reproductive Health Market, By End User
- 6.8.6 Spain Women Reproductive Health Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
  - 6.8.6.1 Spain Women Reproductive Health Market, By Treatment Type
  - 6.8.6.2 Spain Women Reproductive Health Market, By Route of Administration
  - 6.8.6.3 Spain Women Reproductive Health Market, By End User
- 6.8.7 Rest of Europe Women Reproductive Health Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
  - 6.8.7.1 Rest of Europe Women Reproductive Health Market, By Treatment Type
  - 6.8.7.2 Rest of Europe Women Reproductive Health Market, By Route of Administration
  - 6.8.7.3 Rest of Europe Women Reproductive Health Market, By End User

7. Asia Pacific Women Reproductive Health Market: Historic and Forecast

7.1 Asia Pacific Women Reproductive Health Market: Snapshot
7.2 Asia Pacific Women Reproductive Health Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.3 Asia Pacific Women Reproductive Health Market: Key Factors
7.4 Asia Pacific Women Reproductive Health Market: Segment Analysis
7.5 Asia Pacific Women Reproductive Health Market Segmentation: By Treatment Type
- 7.5.1 Asia Pacific Women Reproductive Health Market, By Treatment Type Overview
- 7.5.2 Asia Pacific Women Reproductive Health Market Size, By Menstrual Disorder, By Value, 2020H-2030F (USD Million & CAGR)
- 7.5.3 Asia Pacific Women Reproductive Health Market Size, By Uterine Fibroids/ Endometriosis, By Value, 2020H-2030F (USD Million & CAGR)
- 7.5.4 Asia Pacific Women Reproductive Health Market Size, By Infertility, By Value, 2020H-2030F (USD Million & CAGR)
- 7.5.5 Asia Pacific Women Reproductive Health Market Size, By Menopausal Disorder, By Value, 2020H-2030F (USD Million & CAGR)
7.6 Asia Pacific Women Reproductive Health Market Segmentation: By Route of Administration
- 7.6.1 Asia Pacific Women Reproductive Health Market, By Route of Administration Overview
- 7.6.2 Asia Pacific Women Reproductive Health Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR)
- 7.6.3 Asia Pacific Women Reproductive Health Market Size, By Parenteral, By Value, 2020H-2030F (USD Million & CAGR)
7.7 Asia Pacific Women Reproductive Health Market Segmentation: By End User
- 7.7.1 Asia Pacific Women Reproductive Health Market, By End User Overview
- 7.7.2 Asia Pacific Women Reproductive Health Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
- 7.7.3 Asia Pacific Women Reproductive Health Market Size, By Specialty Centers, By Value, 2020H-2030F (USD Million & CAGR)
- 7.7.4 Asia Pacific Women Reproductive Health Market Size, By At-Home, By Value, 2020H-2030F (USD Million & CAGR)
7.8 Asia Pacific Women Reproductive Health Market Segmentation: By Country
- 7.8.1 Asia Pacific Women Reproductive Health Market, By Country Overview
- 7.8.2 China Women Reproductive Health Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
  - 7.8.2.1 China Women Reproductive Health Market, By Treatment Type
  - 7.8.2.2 China Women Reproductive Health Market, By Route of Administration
  - 7.8.2.3 China Women Reproductive Health Market, By End User
- 7.8.3 Japan Women Reproductive Health Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
  - 7.8.3.1 Japan Women Reproductive Health Market, By Treatment Type
  - 7.8.3.2 Japan Women Reproductive Health Market, By Route of Administration
  - 7.8.3.3 Japan Women Reproductive Health Market, By End User
- 7.8.4 India Women Reproductive Health Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
  - 7.8.4.1 India Women Reproductive Health Market, By Treatment Type
  - 7.8.4.2 India Women Reproductive Health Market, By Route of Administration
  - 7.8.4.3 India Women Reproductive Health Market, By End User
- 7.8.5 Rest of Asia Pacific Women Reproductive Health Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
  - 7.8.5.1 Rest of Asia Pacific Women Reproductive Health Market, By Treatment Type
  - 7.8.5.2 Rest of Asia Pacific Women Reproductive Health Market, By Route of Administration
  - 7.8.5.3 Rest of Asia Pacific Women Reproductive Health Market, By End User

8. Middle East and Africa Women Reproductive Health Market: Historic and Forecast

8.1 Middle East and Africa Women Reproductive Health Market: Snapshot
8.2 Middle East and Africa Women Reproductive Health Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.3 Middle East and Africa Women Reproductive Health Market: Key Factors
8.4 Middle East and Africa Women Reproductive Health Market: Segment Analysis
8.5 Middle East and Africa Women Reproductive Health Market Segmentation: By Treatment Type
- 8.5.1 Middle East and Africa Women Reproductive Health Market, By Treatment Type Overview
- 8.5.2 Middle East and Africa Women Reproductive Health Market Size, By Menstrual Disorder, By Value, 2020H-2030F (USD Million & CAGR)
- 8.5.3 Middle East and Africa Women Reproductive Health Market Size, By Uterine Fibroids/ Endometriosis, By Value, 2020H-2030F (USD Million & CAGR)
- 8.5.4 Middle East and Africa Women Reproductive Health Market Size, By Infertility, By Value, 2020H-2030F (USD Million & CAGR)
- 8.5.5 Middle East and Africa Women Reproductive Health Market, By Menopausal Disorder, By Value, 2020H-2030F (USD Million & CAGR)
8.6 Middle East and Africa Women Reproductive Health Market Segmentation: By Route of Administration
- 8.6.1 Middle East and Africa Women Reproductive Health Market, By Route of Administration Overview
- 8.6.2 Middle East and Africa Women Reproductive Health Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR)
- 8.6.3 Middle East and Africa Women Reproductive Health Market Size, By Parenteral, By Value, 2020H-2030F (USD Million & CAGR)
8.7 Middle East and Africa Women Reproductive Health Market Segmentation: By End User
- 8.7.1 Middle East and Africa Women Reproductive Health Market, By End User Overview
- 8.7.2 Middle East and Africa Women Reproductive Health Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
- 8.7.3 Middle East and Africa Women Reproductive Health Market Size, By Specialty Centers, By Value, 2020H-2030F (USD Million & CAGR)
- 8.7.4 Middle East and Africa Women Reproductive Health Market Size, By At-Home, By Value, 2020H-2030F (USD Million & CAGR)

9. Market Dynamics

9.1 Impact assessment of Market Dynamics on Global Women Reproductive Health Market
9.2 Drivers
9.3 Restraints
9.4 Trends

10. Industry Ecosystem Analysis

10.1 Porter Analysis

11. Competitive Positioning

11.1 Companies' Product Positioning
11.2 Market Share of Leading Companies
11.3 Company Profiling
- 11.3.1 Amgen, Inc.
- 11.3.2 Teva Pharmaceutical
- 11.3.3 Merck & Co., Inc.
- 11.3.4 Bayer AG
- 11.3.5 AbbVie Inc.
- 11.3.6 Agile Therapeutics Inc.
- 11.3.7 Pfizer Inc.
- 11.3.8 Glenmark Pharmaceuticals Ltd.
- 11.3.9 AstraZeneca PLC.
- 11.3.10 Ferring Pharmaceuticals

12. About Us and Disclaimer

List of Figures

Figure 1: Global Women Reproductive Health Market Size, By Value, 2020-2023 (USD Million)
Figure 2: Global Women Reproductive Health Market Size, By Value, 2024-2030 (USD Million)
Figure 3: Global Women Reproductive Health Market Share, By Treatment Type, 2023 (%)
Figure 4: Market Attractiveness Analysis of Global Women Reproductive Health Market, By Treatment Type (2025-2030)
Figure 5: Global Women Reproductive Health Market Size, By Menstrual Disorder, By Value, 2020H-2030F (USD Million & CAGR)
Figure 6: Global Women Reproductive Health Market Absolute Opportunity, By Menstrual Disorder, 2020H-2030F (USD Million)
Figure 7: Global Women Reproductive Health Market Size, By Uterine Fibroids/ Endometriosis, By Value, 2020H-2030F (USD Million & CAGR)
Figure 8: Global Women Reproductive Health Market Absolute Opportunity, By Uterine Fibroids/ Endometriosis, 2020H-2030F (USD Million)
Figure 9: Global Women Reproductive Health Market Size, By Infertility, By Value, 2020H-2030F (USD Million & CAGR)
Figure 10: Global Women Reproductive Health Market Absolute Opportunity, By Infertility, 2020H-2030F (USD Million)
Figure 11: Global Women Reproductive Health Market Size, By Menopausal Disorder, By Value, 2020H-2030F (USD Million & CAGR)
Figure 12: Global Women Reproductive Health Market Absolute Opportunity, By Menopausal Disorder, 2020H-2030F (USD Million)
Figure 13: Market Attractiveness Analysis of Global Women Reproductive Health Market, By Route of Administration (2025-2030)
Figure 14: Global Women Reproductive Health Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR)
Figure 15: Global Women Reproductive Health Market Absolute Opportunity, By Oral, 2020H-2030F (USD Million)
Figure 16: Global Women Reproductive Health Market Size, By Parenteral, By Value, 2020H-2030F (USD Million & CAGR)
Figure 17: Global Women Reproductive Health Market Absolute Opportunity, By Parenteral, 2020H-2030F (USD Million)
Figure 18: Market Attractiveness Analysis of Global Women Reproductive Health Market, By End User (2025-2030)
Figure 19: Global Women Reproductive Health Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
Figure 20: Global Women Reproductive Health Market Absolute Opportunity, By Hospitals, 2020H-2030F (USD Million)
Figure 21: Global Women Reproductive Health Market Size, By Specialty Centers, By Value, 2020H-2030F (USD Million & CAGR)
Figure 22: Global Women Reproductive Health Market Absolute Opportunity, By Specialty Centers, 2020H-2030F (USD Million)
Figure 23: Global Women Reproductive Health Market Size, By At-Home, By Value, 2020H-2030F (USD Million & CAGR)
Figure 24: Global Women Reproductive Health Market Absolute Opportunity, By At-Home, 2020H-2030F (USD Million)
Figure 25: Americas Women Reproductive Health Market Size, By Value, 2020H-2030F (USD Million)
Figure 26: Americas Women Reproductive Health Market Share, By Treatment Type, 2023 (%)
Figure 27: Americas Women Reproductive Health Market, By Menstrual Disorder, By Value, 2020H-2030F (USD Million & CAGR)
Figure 28: Americas Women Reproductive Health Market, By Uterine Fibroids/ Endometriosis, By Value, 2020H-2030F (USD Million & CAGR)
Figure 29: Americas Women Reproductive Health Market, By Infertility, By Value, 2020H-2030F (USD Million & CAGR)
Figure 30: Americas Women Reproductive Health Market, By Menopausal Disorder, By Value, 2020H-2030F (USD Million & CAGR)
Figure 31: Americas Women Reproductive Health Market, By Oral, By Value, 2020H-2030F (USD Million & CAGR)
Figure 32: Americas Women Reproductive Health Market, By Parenteral, By Value, 2020H-2030F (USD Million & CAGR)
Figure 33: Americas Women Reproductive Health Market, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
Figure 34: Americas Women Reproductive Health Market, By Specialty Centers, By Value, 2020H-2030F (USD Million & CAGR)
Figure 35: Americas Women Reproductive Health Market, By At-Home, By Value, 2020H-2030F (USD Million & CAGR)
Figure 36: United States Women Reproductive Health Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 37: United States Women Reproductive Health Market Value, By Route of Administration, 2023 (USD Million)
Figure 38: United States Women Reproductive Health Market Share, By Treatment Type, By Value, 2023 (%)
Figure 39: United States Women Reproductive Health Market Share, By Route of Administration, By Value, 2023 (%)
Figure 40: United States Women Reproductive Health Market Share, By End User, By Value, 2023 (%)
Figure 41: Canada Women Reproductive Health Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 42: Canada Women Reproductive Health Market Value, By Route of Administration, 2023 (USD Million)
Figure 43: Canada Women Reproductive Health Market Share, By Treatment Type, By Value, 2023 (%)
Figure 44: Canada Women Reproductive Health Market Share, By Route of Administration, By Value, 2023 (%)
Figure 45: Canada Women Reproductive Health Market Share, By End User, By Value, 2023 (%)
Figure 46: Rest of Americas Women Reproductive Health Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 47: Rest of Americas Women Reproductive Health Market Value, By Route of Administration, 2023 (USD Million)
Figure 48: Rest of Americas Women Reproductive Health Market Share, By Treatment Type, By Value, 2023 (%)
Figure 49: Rest of Americas Women Reproductive Health Market Share, By Route of Administration, By Value, 2023 (%)
Figure 50: Rest of Americas Women Reproductive Health Market Share, By End User, By Value, 2023 (%)
Figure 51: Europe Women Reproductive Health Market Size, By Value, 2020H-2030F (USD Million)
Figure 52: Europe Women Reproductive Health Market Share, By Treatment Type, 2023 (%)
Figure 53: Europe Women Reproductive Health Market, By Menstrual Disorder, By Value, 2020H-2030F (USD Million & CAGR)
Figure 54: Europe Women Reproductive Health Market, By Uterine Fibroids/ Endometriosis, By Value, 2020H-2030F (USD Million & CAGR)
Figure 55: Europe Women Reproductive Health Market, By Infertility, By Value, 2020H-2030F (USD Million & CAGR)
Figure 56: Europe Women Reproductive Health Market, By Menopausal Disorder, By Value, 2020H-2030F (USD Million & CAGR)
Figure 57: Europe Women Reproductive Health Market, By Oral, By Value, 2020H-2030F (USD Million & CAGR)
Figure 58: Europe Women Reproductive Health Market, By Parenteral, By Value, 2020H-2030F (USD Million & CAGR)
Figure 59: Europe Women Reproductive Health Market, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
Figure 60: Europe Women Reproductive Health Market, By Specialty Centers, By Value, 2020H-2030F (USD Million & CAGR)
Figure 61: Europe Women Reproductive Health Market, By At-Home, By Value, 2020H-2030F (USD Million & CAGR)
Figure 62: United Kingdom Women Reproductive Health Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 63: United Kingdom Women Reproductive Health Market Value, By Route of Administration, 2023 (USD Million)
Figure 64: United Kingdom Women Reproductive Health Market Share, By Treatment Type, By Value, 2023 (%)
Figure 65: United Kingdom Women Reproductive Health Market Share, By Route of Administration, By Value, 2023 (%)
Figure 66: United Kingdom Women Reproductive Health Market Share, By End User, By Value, 2023 (%)
Figure 67: Germany Women Reproductive Health Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 68: Germany Women Reproductive Health Market Value, By Route of Administration, 2023 (USD Million)
Figure 69: Germany Women Reproductive Health Market Share, By Treatment Type, By Value, 2023 (%)
Figure 70: Germany Women Reproductive Health Market Share, By Route of Administration, By Value, 2023 (%)
Figure 71: Germany Women Reproductive Health Market Share, By End User, By Value, 2023 (%)
Figure 72: France Women Reproductive Health Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 73: France Women Reproductive Health Market Value, By Route of Administration, 2023 (USD Million)
Figure 74: France Women Reproductive Health Market Share, By Treatment Type, By Value, 2023 (%)
Figure 75: France Women Reproductive Health Market Share, By Route of Administration, By Value, 2023 (%)
Figure 76: France Women Reproductive Health Market Share, By End User, By Value, 2023 (%)
Figure 77: Italy Women Reproductive Health Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 78: Italy Women Reproductive Health Market Value, By Route of Administration, 2023 (USD Million)
Figure 79: Italy Women Reproductive Health Market Share, By Treatment Type, By Value, 2023 (%)
Figure 80: Italy Women Reproductive Health Market Share, By Route of Administration, By Value, 2023 (%)
Figure 81: Italy Women Reproductive Health Market Share, By End User, By Value, 2023 (%)
Figure 82: Spain Women Reproductive Health Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 83: Spain Women Reproductive Health Market Value, By Route of Administration, 2023 (USD Million)
Figure 84: Spain Women Reproductive Health Market Share, By Treatment Type, By Value, 2023 (%)
Figure 85: Spain Women Reproductive Health Market Share, By Route of Administration, By Value, 2023 (%)
Figure 86: Spain Women Reproductive Health Market Share, By End User, By Value, 2023 (%)
Figure 87: Rest of Europe Women Reproductive Health Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 88: Rest of Europe Women Reproductive Health Market Value, By Route of Administration, 2023 (USD Million)
Figure 89: Rest of Europe Women Reproductive Health Market Share, By Treatment Type, By Value, 2023 (%)
Figure 90: Rest of Europe Women Reproductive Health Market Share, By Route of Administration, By Value, 2023 (%)
Figure 91: Rest of Europe Women Reproductive Health Market Share, By End User, By Value, 2023 (%)
Figure 92: Asia-Pacific Women Reproductive Health Market Size, By Value, 2020H-2030F (USD Million)
Figure 93: Asia-Pacific Women Reproductive Health Market Share, By Treatment Type, 2023 (%)
Figure 94: Asia-Pacific Women Reproductive Health Market, By Menstrual Disorder, By Value, 2020H-2030F (USD Million & CAGR)
Figure 95: Asia-Pacific Women Reproductive Health Market, By Uterine Fibroids/ Endometriosis, By Value, 2020H-2030F (USD Million & CAGR)
Figure 96: Asia-Pacific Women Reproductive Health Market, By Infertility, By Value, 2020H-2030F (USD Million & CAGR)
Figure 97: Asia-Pacific Women Reproductive Health Market, By Menopausal Disorder, By Value, 2020H-2030F (USD Million & CAGR)
Figure 98: Asia-Pacific Women Reproductive Health Market, By Oral, By Value, 2020H-2030F (USD Million & CAGR)
Figure 99: Asia-Pacific Women Reproductive Health Market, By Parenteral, By Value, 2020H-2030F (USD Million & CAGR)
Figure 100: Asia-Pacific Women Reproductive Health Market, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
Figure 101: Asia-Pacific Women Reproductive Health Market, By Specialty Centers, By Value, 2020H-2030F (USD Million & CAGR)
Figure 102: Asia-Pacific Women Reproductive Health Market, By At-Home, By Value, 2020H-2030F (USD Million & CAGR)
Figure 103: China Women Reproductive Health Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 104: China Women Reproductive Health Market Value, By Route of Administration, 2023 (USD Million)
Figure 105: China Women Reproductive Health Market Share, By Treatment Type, By Value, 2023 (%)
Figure 106: China Women Reproductive Health Market Share, By Route of Administration, By Value, 2023 (%)
Figure 107: China Women Reproductive Health Market Share, By End User, By Value, 2023 (%)
Figure 108: Japan Women Reproductive Health Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 109: Japan Women Reproductive Health Market Value, By Route of Administration, 2023 (USD Million)
Figure 110: Japan Women Reproductive Health Market Share, By Treatment Type, By Value, 2023 (%)
Figure 111: Japan Women Reproductive Health Market Share, By Route of Administration, By Value, 2023 (%)
Figure 112: Japan Women Reproductive Health Market Share, By End User, By Value, 2023 (%)
Figure 113: India Women Reproductive Health Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 114: India Women Reproductive Health Market Value, By Route of Administration, 2023 (USD Million)
Figure 115: India Women Reproductive Health Market Share, By Treatment Type, By Value, 2023 (%)
Figure 116: India Women Reproductive Health Market Share, By Route of Administration, By Value, 2023 (%)
Figure 117: India Women Reproductive Health Market Share, By End User, By Value, 2023 (%)
Figure 118: Rest of Asia-Pacific Women Reproductive Health Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 119: Rest of Asia-Pacific Women Reproductive Health Market Value, By Route of Administration, 2023 (USD Million)
Figure 120: Rest of Asia-Pacific Women Reproductive Health Market Share, By Treatment Type, By Value, 2023 (%)
Figure 121: Rest of Asia-Pacific Women Reproductive Health Market Share, By Route of Administration, By Value, 2023 (%)
Figure 122: Rest of Asia-Pacific Women Reproductive Health Market Share, By End User, By Value, 2023 (%)
Figure 123: Middle East and Africa Women Reproductive Health Market Size, By Value, 2020H-2030F (USD Million)
Figure 124: Middle East and Africa Women Reproductive Health Market Share, By Treatment Type, 2023 (%)
Figure 125: Middle East and Africa Women Reproductive Health Market, By Menstrual Disorder, By Value, 2020H-2030F (USD Million & CAGR)
Figure 126: Middle East and Africa Women Reproductive Health Market, By Uterine Fibroids/ Endometriosis, By Value, 2020H-2030F (USD Million & CAGR)
Figure 127: Middle East and Africa Women Reproductive Health Market, By Infertility, By Value, 2020H-2030F (USD Million & CAGR)
Figure 128: Middle East and Africa Women Reproductive Health Market, By Menopausal Disorder, By Value, 2020H-2030F (USD Million & CAGR)
Figure 129: Middle East and Africa Women Reproductive Health Market, By Oral, By Value, 2020H-2030F (USD Million & CAGR)
Figure 130: Middle East and Africa Women Reproductive Health Market, By Parenteral, By Value, 2020H-2030F (USD Million & CAGR)
Figure 131: Middle East and Africa Women Reproductive Health Market, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
Figure 132: Middle East and Africa Women Reproductive Health Market, By Specialty Centers, By Value, 2020H-2030F (USD Million & CAGR)
Figure 133: Middle East and Africa Women Reproductive Health Market, By At-Home, By Value, 2020H-2030F (USD Million & CAGR)
Figure 134: Global Impact of Drivers and Restraints
Figure 135: Market Share of Prominent Companies of Women Reproductive Health, 2023 (%)
Figure 136: Amgen, Inc. Revenues, 2021-2023 (USD Million)
Figure 137: Amgen, Inc. Revenues, By Geographic Segments, 2022 (%)
Figure 138: Amgen, Inc. Revenue , By Products, 2022 (%)
Figure 139: Teva Pharmaceuticals Revenues, 2021-2023 (USD Million)
Figure 140: Teva Pharmaceuticals Revenue , By Geographical Segments, 2023 (%)
Figure 141: Merck & Co., Inc. Revenues, 2021-2023 (USD Billion)
Figure 142: Merck & Co., Inc. Revenues, By Geographic Segments, 2023 (%)
Figure 143: Merck & Co., Inc. Revenue , By Business Segments, 2023 (%)
Figure 144: Bayer AG Revenues, 2020-2022 (USD Billion)
Figure 145: Bayer AG Revenues, By Geographic Segments, 2023 (%)
Figure 146: Bayer AG Revenues, By Business Segments, 2023 (%)
Figure 147: AbbVie Inc. Revenue, 2021-2023 (USD Million)
Figure 148: AbbVie Inc. Revenue, By Geographical Segments, 2023 (%)
Figure 149: AbbVie Inc. Revenue, By Business Segments, 2023 (%)
Figure 150: Agile Therapeutics Inc Revenue, 2021-2023 (USD Million)
Figure 151: Pfizer Inc. Revenue, 2021-2023 (USD Million)
Figure 152: Pfizer Inc. Revenue, By Geographical Segments, 2023 (%)
Figure 153: Pfizer Inc. Revenue, By Business Segments, 2023 (%)
Figure 154: Glenmark Revenue, 2021-2023 (USD Million)
Figure 155: Glenmark Revenue, By Geographical Segments, 2023 (%)
Figure 156: Glenmark Revenue, By Business Segments, 2023 (%)
Figure 157: AstraZeneca plc. Revenue, 2021-2023 (USD Million)
Figure 158: AstraZeneca plc. Revenue, By Geographical Segments, 2023 (%)
Figure 159: AstraZeneca plc. Revenue, By Business Segments, 2023 (%)

List of Tables

Table A1: Global Impact of Macro Economic Factors, By Region

Table A2: Women Reproductive Health Drugs in Pipeline

Table A3: United States Women Reproductive Health Market, By Treatment Type, By Value, 2020-2023 (USD Million)

Table A4: United States Women Reproductive Health Market, By Treatment Type, By Value, 2024-2030 (USD Million)

Table A5: United States Women Reproductive Health Market, By Route of Administration, By Value, 2020-2023 (USD Million)

Table A6: United States Women Reproductive Health Market, By Route of Administration, By Value, 2024-2030 (USD Million)

Table A7: United States Women Reproductive Health Market, By End User, By Value, 2020-2023 (USD Million)

Table A8: United States Women Reproductive Health Market, By End User, By Value, 2024-2030 (USD Million)

Table A9: Canada Women Reproductive Health Market, By Treatment Type, By Value, 2020-2023 (USD Million)

Table A10: Canada Women Reproductive Health Market, By Treatment Type, By Value, 2024-2030 (USD Million)

Table A11: Canada Women Reproductive Health Market, By Route of Administration, By Value, 2020-2023 (USD Million)

Table A12: Canada Women Reproductive Health Market, By Route of Administration, By Value, 2024-2030 (USD Million)

Table A13: Canada Women Reproductive Health Market, By End User, By Value, 2020-2023 (USD Million)

Table A14: Canada Women Reproductive Health Market, By End User, By Value, 2024-2030 (USD Million)

Table A15: Rest of Americas Women Reproductive Health Market, By Treatment Type, By Value, 2020-2023 (USD Million)

Table A16: Rest of Americas Women Reproductive Health Market, By Treatment Type, By Value, 2024-2030 (USD Million)

Table A17: Rest of Americas Women Reproductive Health Market, By Route of Administration, By Value, 2020-2023 (USD Million)

Table A18: Rest of Americas Women Reproductive Health Market, By Route of Administration, By Value, 2024-2030 (USD Million)

Table A19: Rest of Americas Women Reproductive Health Market, By End User, By Value, 2020-2023 (USD Million)

Table A20: Rest of Americas Women Reproductive Health Market, By End User, By Value, 2024-2030 (USD Million)

Table A21: United Kingdom Women Reproductive Health Market, By Treatment Type, By Value, 2020-2023 (USD Million)

Table A22: United Kingdom Women Reproductive Health Market, By Treatment Type, By Value, 2024-2030 (USD Million)

Table A23: United Kingdom Women Reproductive Health Market, By Route of Administration, By Value, 2020-2023 (USD Million)

Table A24: United Kingdom Women Reproductive Health Market, By Route of Administration, By Value, 2024-2030 (USD Million)

Table A25: United Kingdom Women Reproductive Health Market, By End User, By Value, 2020-2023 (USD Million)

Table A26: United Kingdom Women Reproductive Health Market, By End User, By Value, 2024-2030 (USD Million)

Table A27: Germany Women Reproductive Health Market, By Treatment Type, By Value, 2020-2023 (USD Million)

Table A28: Germany Women Reproductive Health Market, By Treatment Type, By Value, 2024-2030 (USD Million)

Table A29: Germany Women Reproductive Health Market, By Route of Administration, By Value, 2020-2023 (USD Million)

Table A30: Germany Women Reproductive Health Market, By Route of Administration, By Value, 2024-2030 (USD Million)

Table A31: Germany Women Reproductive Health Market, By End User, By Value, 2020-2023 (USD Million)

Table A32: Germany Women Reproductive Health Market, By End User, By Value, 2024-2030 (USD Million)

Table A33: France Women Reproductive Health Market, By Treatment Type, By Value, 2020-2023 (USD Million)

Table A34: France Women Reproductive Health Market, By Treatment Type, By Value, 2024-2030 (USD Million)

Table A35: France Women Reproductive Health Market, By Route of Administration, By Value, 2020-2023 (USD Million)

Table A36: France Women Reproductive Health Market, By Route of Administration, By Value, 2024-2030 (USD Million)

Table A37: France Women Reproductive Health Market, By End User, By Value, 2020-2023 (USD Million)

Table A38: France Women Reproductive Health Market, By End User, By Value, 2024-2030 (USD Million)

Table A39: Italy Women Reproductive Health Market, By Treatment Type, By Value, 2020-2023 (USD Million)

Table A40: Italy Women Reproductive Health Market, By Treatment Type, By Value, 2024-2030 (USD Million)

Table A41: Italy Women Reproductive Health Market, By Route of Administration, By Value, 2020-2023 (USD Million)

Table A42: Italy Women Reproductive Health Market, By Route of Administration, By Value, 2024-2030 (USD Million)

Table A43: Italy Women Reproductive Health Market, By End User, By Value, 2020-2023 (USD Million)

Table A44: Italy Women Reproductive Health Market, By End User, By Value, 2024-2030 (USD Million)

Table A45: Spain Women Reproductive Health Market, By Treatment Type, By Value, 2020-2023 (USD Million)

Table A46: Spain Women Reproductive Health Market, By Treatment Type, By Value, 2024-2030 (USD Million)

Table A47: Spain Women Reproductive Health Market, By Route of Administration, By Value, 2020-2023 (USD Million)

Table A48: Spain Women Reproductive Health Market, By Route of Administration, By Value, 2024-2030 (USD Million)

Table A49: Spain Women Reproductive Health Market, By End User, By Value, 2020-2023 (USD Million)

Table A50: Spain Women Reproductive Health Market, By End User, By Value, 2024-2030 (USD Million)

Table A51: Rest of Europe Women Reproductive Health Market, By Treatment Type, By Value, 2020-2023 (USD Million)

Table A52: Rest of Europe Women Reproductive Health Market, By Treatment Type, By Value, 2024-2030 (USD Million)

Table A53: Rest of Europe Women Reproductive Health Market, By Route of Administration, By Value, 2020-2023 (USD Million)

Table A54: Rest of Europe Women Reproductive Health Market, By Route of Administration, By Value, 2024-2030 (USD Million)

Table A55: Rest of Europe Women Reproductive Health Market, By End User, By Value, 2020-2023 (USD Million)

Table A56: Rest of Europe Women Reproductive Health Market, By End User, By Value, 2024-2030 (USD Million)

Table A57: China Women Reproductive Health Market, By Treatment Type, By Value, 2020-2023 (USD Million)

Table A58: China Women Reproductive Health Market, By Treatment Type, By Value, 2024-2030 (USD Million)

Table A59: China Women Reproductive Health Market, By Route of Administration, By Value, 2020-2023 (USD Million)

Table A60: China Women Reproductive Health Market, By Route of Administration, By Value, 2024-2030 (USD Million)

Table A61: China Women Reproductive Health Market, By End User, By Value, 2020-2023 (USD Million)

Table A62: China Women Reproductive Health Market, By End User, By Value, 2024-2030 (USD Million)

Table A63: Japan Women Reproductive Health Market, By Treatment Type, By Value, 2020-2023 (USD Million)

Table A64: Japan Women Reproductive Health Market, By Treatment Type, By Value, 2024-2030 (USD Million)

Table A65: Japan Women Reproductive Health Market, By Route of Administration, By Value, 2020-2023 (USD Million)

Table A66: Japan Women Reproductive Health Market, By Route of Administration, By Value, 2024-2030 (USD Million)

Table A67: Japan Women Reproductive Health Market, By End User, By Value, 2020-2023 (USD Million)

Table A68: Japan Women Reproductive Health Market, By End User, By Value, 2024-2030 (USD Million)

Table A69: India Women Reproductive Health Market, By Treatment Type, By Value, 2020-2023 (USD Million)

Table A70: India Women Reproductive Health Market, By Treatment Type, By Value, 2024-2030 (USD Million)

Table A71: India Women Reproductive Health Market, By Route of Administration, By Value, 2020-2023 (USD Million)

Table A72: India Women Reproductive Health Market, By Route of Administration, By Value, 2024-2030 (USD Million)

Table A73: India Women Reproductive Health Market, By End User, By Value, 2020-2023 (USD Million)

Table A74: India Women Reproductive Health Market, By End User, By Value, 2024-2030 (USD Million)

Table A75: Rest of Asia-Pacific Women Reproductive Health Market, By Treatment Type, By Value, 2020-2023 (USD Million)

Table A76: Rest of Asia-Pacific Women Reproductive Health Market, By Treatment Type, By Value, 2024-2030 (USD Million)

Table A77: Rest of Asia-Pacific Women Reproductive Health Market, By Route of Administration, By Value, 2020-2023 (USD Million)

Table A78: Rest of Asia-Pacific Women Reproductive Health Market, By Route of Administration, By Value, 2024-2030 (USD Million)

Table A79: Rest of Asia-Pacific Women Reproductive Health Market, By End User, By Value, 2020-2023 (USD Million)

Table A80: Rest of Asia-Pacific Women Reproductive Health Market, By End User, By Value, 2024-2030 (USD Million)

Table A81: Amgen, Inc. Key Financials, 2021-2023

Table A82: Teva Pharmaceuticals Key Company Financials, 2021-2023

Table A83: Merck & Co., Inc. Key Financials, 2021-2023

Table A84: Bayer AG Key Financials, 2021-2023

Table A85: AbbVie Inc. Key Company Financials, 2021-2023

Table A86: Agile Therapeutics Inc. Key Company Financials, 2021-2023

Table A87: Pfizer Inc. Key Company Financials, 2021-2023

Table A88: Glenmark Key Company Financials, 2021-2023

Table A89: AstraZeneca plc. Key Company Financials, 2021-2023